Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392)
China flag China · Delayed Price · Currency is CNY
68.47
-0.75 (-1.08%)
Sep 6, 2024, 3:00 PM CST

Beijing Wantai Biological Pharmacy Enterprise Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
86,83495,280114,799134,45987,383-
Upgrade
Market Cap Growth
-1.33%-17.00%-14.62%53.87%--
Upgrade
Enterprise Value
81,65990,027108,497134,05286,784-
Upgrade
Last Close Price
68.4774.7889.12107.3769.72-
Upgrade
PE Ratio
-75.5323.5165.35123.08-
Upgrade
PS Ratio
31.4317.2910.2623.3837.12-
Upgrade
PB Ratio
6.687.409.1429.4733.86-
Upgrade
P/FCF Ratio
176.49251.9635.84212.031123.62-
Upgrade
P/OCF Ratio
55.6961.9627.7879.94186.63-
Upgrade
EV/Sales Ratio
30.1016.349.7023.3136.86-
Upgrade
EV/EBITDA Ratio
-308.0657.2720.0957.44107.25-
Upgrade
EV/EBIT Ratio
-160.2766.0020.6159.91119.74-
Upgrade
EV/FCF Ratio
165.98238.0733.88211.391115.90-
Upgrade
Debt / Equity Ratio
0.020.020.020.060.030.01
Upgrade
Debt / EBITDA Ratio
-0.190.050.120.100.09
Upgrade
Debt / FCF Ratio
0.520.820.090.451.000.19
Upgrade
Asset Turnover
0.170.350.961.090.830.59
Upgrade
Inventory Turnover
0.991.131.641.711.491.54
Upgrade
Quick Ratio
4.043.493.201.671.861.24
Upgrade
Current Ratio
4.483.863.491.962.391.80
Upgrade
Return on Equity (ROE)
-1.53%9.80%56.79%58.22%32.77%14.25%
Upgrade
Return on Assets (ROA)
-1.93%5.34%28.27%26.51%15.98%4.69%
Upgrade
Return on Capital (ROIC)
-2.28%6.55%37.20%37.26%21.27%6.24%
Upgrade
Earnings Yield
-0.23%1.31%4.13%1.50%0.77%-
Upgrade
FCF Yield
0.57%0.40%2.79%0.47%0.09%-
Upgrade
Dividend Yield
0.47%0.43%0.80%0.09%0.13%-
Upgrade
Payout Ratio
0.00%72.73%2.69%5.58%0.24%0.50%
Upgrade
Buyback Yield / Dilution
1.94%-0.86%-1.55%-2.96%-8.71%-2.96%
Upgrade
Total Shareholder Return
2.41%-0.43%-0.75%-2.87%-8.59%-2.96%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.